Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Cell Biol ; 25(22): 10079-86, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16260621

RESUMO

p53 binding protein 1 (53BP1) is a putative DNA damage sensor that accumulates at sites of double-strand breaks (DSBs) in a manner dependent on histone H2AX. Here we show that the loss of one or both copies of 53BP1 greatly accelerates lymphomagenesis in a p53-null background, suggesting that 53BP1 and p53 cooperate in tumor suppression. A subset of 53BP1-/- p53-/- lymphomas, like those in H2AX-/- p53-/- mice, were diploid and harbored clonal translocations involving antigen receptor loci, indicating misrepair of DSBs during V(D)J recombination as one cause of oncogenic transformation. Loss of a single 53BP1 allele compromised genomic stability and DSB repair, which could explain the susceptibility of 53BP1+/- mice to tumorigenesis. In addition to structural aberrations, there were high rates of chromosomal missegregation and accumulation of aneuploid cells in 53BP1-/- p53+/+ and 53BP1-/- p53-/- tumors as well as in primary 53BP1-/- splenocytes. We conclude that 53BP1 functions as a dosage-dependent caretaker that promotes genomic stability by a mechanism that preserves chromosome structure and number.


Assuntos
Peptídeos e Proteínas de Sinalização Intracelular/fisiologia , Neoplasias/genética , Fosfoproteínas/fisiologia , Proteína Supressora de Tumor p53/fisiologia , Alelos , Motivos de Aminoácidos , Animais , Sítios de Ligação , Western Blotting , Células Cultivadas , Centrossomo/ultraestrutura , Aberrações Cromossômicas , Cromossomos/ultraestrutura , Cruzamentos Genéticos , Reparo do DNA , Feminino , Genes Supressores de Tumor , Predisposição Genética para Doença , Hibridização in Situ Fluorescente , Cariotipagem , Linfoma/metabolismo , Masculino , Camundongos , Camundongos Transgênicos , Microscopia de Fluorescência , Neoplasias/patologia , Receptores de Antígenos/metabolismo , Recombinação Genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Baço/citologia , Fatores de Tempo , Translocação Genética , Proteína Supressora de Tumor p53/metabolismo , Proteína 1 de Ligação à Proteína Supressora de Tumor p53
2.
Mol Ther ; 12(5): 835-41, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16054438

RESUMO

The sodium-iodide symporter (NIS) is primarily a thyroid protein, providing for the accumulation of iodide for biosynthesis of thyroid hormones. Native NIS expression has made possible the use of radioactive iodide to image and treat thyroid disease successfully. The current study, using adult male beagle dogs, was carried out in preparation for a Phase I clinical trial of adenovirus-mediated NIS gene (approved symbol SLC5A5) therapy for prostate cancer. Direct intraprostatic injection of virus (Ad5/CMV/NS) was followed by iv injection of 3 mCi 123I and serial image acquisition. The dogs were then given a therapeutic dose of 131I (116 mCi/m2) and observed for 7 days. SPECT/CT fusion imaging revealed clear images of the NIS-transduced prostates. Dosimetry calculations revealed an average absorbed dose to the prostate of 23 +/- 42 cGy/mCi 131I, with acceptably low radiation doses to other organs. This study demonstrated the successful introduction of localized NIS expression in the prostate gland of dogs, with no vector-related toxicity observed. None of the animals experienced any surgical complications, and serum chemistry panels showed no significant change following therapy. The results presented provide further evidence of the safety and efficacy of NIS as a therapeutic gene and support translation of this work into the clinical setting.


Assuntos
Adenoviridae/genética , Terapia Genética , Neoplasias da Próstata/terapia , Simportadores/uso terapêutico , Animais , Modelos Animais de Doenças , Cães , Radioisótopos do Iodo/uso terapêutico , Masculino , Neoplasias da Próstata/diagnóstico por imagem , Radiometria , Cintilografia , Compostos Radiofarmacêuticos/uso terapêutico , Simportadores/genética , Transdução Genética , Transfecção
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa